People who take nonsteroidal anti-inflammatory drugs NSAIDs other than aspirin such as etodolac may have a higher risk of having a heart attack or a stroke than people who do not take these medications. Etodolac Extended-Release Tablets are a non-steroidal anti-inflammatory drug NSAID that exhibits anti-inflammatory, analgesic, and antipyretic activities in animal models. Items listed in bold indicate initially developed compounds of specific groups.
Etodolac is best discontinued at least four days in advance of surgery. If you will be undergoing a coronary artery bypass graft CABG; a type of heart surgeryyou should not take etodolac right before or right after the surgery. It is not known whether etodolac is excreted in human milk.
To minimize the potential risk for an adverse CV event in NSAID-treated patients, use the lowest effective dose for the shortest duration possible. Keep all appointments with your doctor and the laboratory.
Tell your healthcare provider about all of the medicines you take, including prescription or over-the- counter medicines, vitamins or herbal supplements.
Other metabolites remain to be identified. The extent of accumulation of hydroxylated-etodolac metabolites in patients with renal dysfunction has not been studied.
Prostaglandin D 2 Treprostinil Antagonists: Ask your pharmacist any questions you have about refilling your prescription. Retrieved from " https: Emergency help should be sought in cases where an anaphylactoid reaction occurs. Etodolac Extended-Release Tablets are contraindicated in patients with known hypersensitivity to etodolac. These serious events may occur without warning.
The effects of Etodolac Extended-Release Tablets on labor and delivery in pregnant women are unknown.
Unlike aspirin, their effect on platelet function is quantitatively less, of shorter duration, and reversible. It has the following structural formula:. In addition, rare cases of severe hepatic reactions, including jaundice and fatal fulminant hepatitis, liver necrosis and hepatic failure, some of them with fatal outcomes have been reported.
This risk may occur early in treatment and may increase with duration of use [ see Warnings and Precautions ]. Patients receiving Etodolac Extended-Release Tablets who may be adversely affected by alterations in platelet function, such as those with coagulation disorders or patients receiving anticoagulants, should be carefully monitored. Retinoids Selenium selenium tetrachloridesodium seleniteselenium disulfide. NSAIDs are used to treat pain and redness, swelling, and heat inflammation from medical conditions such as different types of arthritis, menstrual cramps, and other types of short-term pain.
For the relief of the signs and symptoms of osteoarthritis or rheumatoid arthritis, the recommended starting dose of Etodolac Extended-Release Tablets is to mg given orally once per day. Etodolac tablets, capsules, and extended-release long-acting tablets are used to relieve pain, tenderness, swelling, and stiffness caused by osteoarthritis arthritis caused by a breakdown of the lining of the joints and rheumatoid arthritis arthritis caused by swelling of the lining of the joints.
Etodolac may cause side effects.